HENRY SCHEIN INC (HSIC) Stock News
NASDAQ:HSIC - Nasdaq - US8064071025 - Common Stock - Currency: USD
HSIC Latest News, Press Relases and Analysis
Henry Schein Medical Announces Winner of Its 2025 Rising Star Award
Q4 Earnings Highs And Lows: Envista (NYSE:NVST) Vs The Rest Of The Dental Equipment & Technology Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Envista (NYSE:NVST) and the best and worst performers in the dental equipment & technology industry.
Henry Schein to Webcast First Quarter 2025 Conference Call on Monday, May 5th, 2025, at 8:00 a.m. ET
Henry Schein Received Validation of Net-Zero Science-Based Targets
Why Is Henry Schein (HSIC) Down 3.9% Since Last Earnings Report?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mentions: WST
3 Reasons to Sell HSIC and 1 Stock to Buy Instead
Since September 2024, Henry Schein has been in a holding pattern, floating around $72.51.
Mentions: COST
Ethisphere Names Henry Schein as One of the 2025 World's Most Ethical Companies® for 14th Consecutive Year
Dental Equipment & Technology Stocks Q4 In Review: Henry Schein (NASDAQ:HSIC) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and worst performers in the dental equipment & technology industry.
Henry Schein to Participate in Upcoming Investor Conference in March
Nominations Now Open for Henry Schein Medical’s Athletics and Schools 2025 Rising Star Award
Henry Schein (NASDAQ:HSIC) Reports Sales Below Analyst Estimates In Q4 Earnings
Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 5.8% year on year to $3.19 billion. Its non-GAAP profit of $1.19 per share was 1.6% below analysts’ consensus estimates.
Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance
Henry Schein (HSIC) Q4 Earnings Report Preview: What To Look For
Dental and Medical products company Henry Schein (NASDAQ:HSIC) will be reporting results tomorrow morning. Here’s what investors should know.
3 Reasons HSIC is Risky and 1 Stock to Buy Instead
Henry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 13.3% to $77.62 per share while the index has gained 12.2%.
Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children
Mentions: CL
